Major depressive disorder (MDD) is a debilitating psychiatric condition characterized by a persistently low mood, a lack of ...

The US Food and Drug Administration is allowing the use of Rejoyn, the first prescription digital treatment for major depressive disorder. Rejoyn, made by Otsuka Pharmaceutical and Click Therapeutics, ...

For some, the holidays, a time most see as a time of joy, can be a difficult season, and mental health experts are pointing ...

New findings suggest that a protein known as Reelin could play a role in treating both “leaky gut” and severe depression.

The approval of medicines called second-generation antipsychotics has allowed major depressive disorder (MDD) and other conditions linked to it to be treated. A person with MDD is usually prescribed ...

You can live for years with obstructive sleep apnea and never know it. The condition repeatedly narrows your upper airway ...

On the first Sunday of November, when the majority of the United States set their clocks an hour earlier, the resulting ...

Intra-Cellular Therapies’ surging antipsychotic Caplyta has scored again with remarkable trial results, fueling its bid for a third and potentially most lucrative indication—major depressive disorder ...

Mental health professionals use the DSM to standardize the diagnosis and treatment processes for mental health conditions, including types of depression. The Diagnostic and Statistical Manual of ...

Biohaven’s phase 2 proof-of-concept study with BHV-7000 in major depressive disorder fails to meet its primary endpoint: New Haven, Connecticut Monday, December 29, 2025, 13:00 ...